EBOS Group Ltd
OTC:EBOSY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
EBOS Group Ltd
OTC:EBOSY
|
AU |
|
Informed Technologies India Ltd
BSE:504810
|
IN |
|
Avid Bioservices Inc
NASDAQ:CDMO
|
US |
Relative Value
The Relative Value of one EBOSY stock under the Base Case scenario is 41.65 USD. Compared to the current market price of 37.69 USD, EBOS Group Ltd is Undervalued by 10%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
EBOSY Competitors Multiples
EBOS Group Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.7B USD | 0.8 | 48.1 | 31.8 | 31.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
107.9B USD | 0.3 | 24.9 | 17.5 | 19.6 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
63B USD | 0.2 | 38.8 | 13.7 | 17.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD | 0.2 | 38.4 | 13.6 | 17.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.7B USD | 0.2 | 29.3 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.6 | 33 | 24.6 | 24.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
60.4B CNY | 0.2 | 10.7 | 14.8 | 14.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.7 | 21.7 | 10.5 | 14.8 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.9B CNY | 1.4 | 15.9 | 12.3 | 12.3 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.7B HKD | 0.1 | 7.8 | 1.3 | 1.7 |